Biotechnology stocks have seen plenty of volatility thus far in 2014 as investors were taken on more swings than a playground. The price action in recent days however has once again looked constructive and CELG is looking itchy for another break higher.

Serge Berger
TheSteadyTrader.com

GET OUR FREE DAILY TRADING VIDEOS

Delivered to your inbox!

You should get your first video tomorrow!

Pin It on Pinterest

Share This